Ji-Hyun Lee, Dr.P.H. - Publications

Affiliations: 
2003 University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Biostatistics Biology

66 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Salloum RG, Huo J, Lee JH, Lee J, Dallery J, George T, Warren G. Tobacco and E-cigarette use among cancer survivors in the United States. Plos One. 14: e0226110. PMID 31815948 DOI: 10.1371/Journal.Pone.0226110  0.306
2019 Greenbaum A, Martin DR, Bocklage T, Lee JH, Ness SA, Rajput A. Tumor Heterogeneity as a Predictor of Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer. Clinical Colorectal Cancer. PMID 30935775 DOI: 10.1016/J.Clcc.2019.02.003  0.306
2018 Kinney AY, Howell R, Ruckman R, McDougall JA, Boyce TW, Vicuña B, Lee JH, Guest DD, Rycroft R, Valverde PA, Gallegos KM, Meisner A, Wiggins CL, Stroup A, Paddock LE, et al. Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial. Contemporary Clinical Trials. 73: 123-135. PMID 30236776 DOI: 10.1016/J.Cct.2018.09.005  0.341
2018 Bishnoi R, Shah C, Hincapie Echeverri J, Robinson K, Wang Y, Lee J, Schmit JM. Lung cancer: Significance of place of diagnosis. Journal of Clinical Oncology. 36: 60-60. DOI: 10.1200/Jco.2018.36.34_Suppl.60  0.365
2018 Zheng Z, Chen L, Lee J, Royce M, Schroeder T, Lee DY. Racial/ethnic disparities in skeletal-related events among women treated with bisphosphonate therapy for bone metastasis secondary to breast cancer. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2018.36.15_Suppl.E13092  0.317
2018 Rivera M, Dominguez D, Pauken C, Romero E, Kenney SR, Shi Y, Lee J, Gillette J, Hudson LG, Wandinger-Ness A. Abstract 3159: Rac1 and Cdc42 as drivers in ovarian cancer metastasis Cancer Research. 78: 3159-3159. DOI: 10.1158/1538-7445.Am2018-3159  0.348
2017 Akbari MR, Zhang S, Cragun D, Lee JH, Coppola D, McLaughlin J, Risch HA, Rosen B, Shaw P, Sellers TA, Schildkraut J, Narod SA, Pal T. Correlation between germline mutations in MMR genes and microsatellite instability in ovarian cancer specimens. Familial Cancer. PMID 28176205 DOI: 10.1007/S10689-017-9973-1  0.304
2017 Adams SF, Rixe O, Lee J, McCance DJ, Westgate S, Eberhardt SC, Rutledge T, Muller C. Phase I study combining olaparib and tremelimumab for the treatment of women with BRCA-deficient recurrent ovarian cancer. Journal of Clinical Oncology. 35: e17052-e17052. DOI: 10.1200/Jco.2017.35.15_Suppl.E17052  0.326
2017 Lauer RC, Barry M, Wu J, Lee J, McCance DJ, Du R, Rao A, Dobroff AS, Dias-Neto E, Chen I, Pasqualini R, Arap W. Evaluation of PRUNE2 and PCA3 expression as metastasis predictors in Gleason 7 prostate cancer. Journal of Clinical Oncology. 35: e16583-e16583. DOI: 10.1200/Jco.2017.35.15_Suppl.E16583  0.303
2016 Rajput A, Bocklage T, Greenbaum A, Lee JH, Ness SA. Mutant-Allele Tumor Heterogeneity Scores Correlate With Risk of Metastases in Colon Cancer. Clinical Colorectal Cancer. PMID 28073683 DOI: 10.1016/J.Clcc.2016.11.004  0.336
2016 Rollison DE, Komrokji R, Lee JH, Hampras S, Fulp W, Fisher K, Baz R, Nishihori T, Xu Q, Olesnyckyj M, Kenvin L, Knight R, Sullivan D, Alsina M, Dalton W, et al. Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide. Leukemia & Lymphoma. 1-9. PMID 27424609 DOI: 10.1080/10428194.2016.1207763  0.318
2016 Ko NY, Snyder FR, Raich PC, Paskett ED, Dudley DJ, Lee JH, Levine PH, Freund KM. Racial and ethnic differences in patient navigation: Results from the Patient Navigation Research Program. Cancer. PMID 27227342 DOI: 10.1002/Cncr.30109  0.335
2015 Ko N, Snyder F, Raich PC, Paskett ED, Dudley D, Lee J, Levine PH, Freund KM. The impact of patient navigation on racial and ethnic disparities: Results from the patient navigation research program. Journal of Clinical Oncology. 33: 6510-6510. DOI: 10.1200/Jco.2015.33.15_Suppl.6510  0.308
2015 Laronga C, Sun W, Siegel E, Lee J, Fulp WJ, Jacobsen PB, Gray JE. Abstract P2-03-15: Re-assessment of 21-gene breast cancer assay utilization as a quality indicator by the Florida Initiative for Quality Cancer Care (FIQCC) Consortium Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P2-03-15  0.344
2014 Tanvetyanon T, Lee JH, Fulp WJ, Schreiber F, Brown RH, Levine RM, Cartwright TH, Abesada-Terk G, Kim GP, Alemany C, Faig D, Sharp PV, Markham MJ, Malafa M, Jacobsen PB. Changes in the care of non-small-cell lung cancer after audit and feedback: the Florida initiative for quality cancer care. Journal of Oncology Practice / American Society of Clinical Oncology. 10: e247-54. PMID 24737876 DOI: 10.1200/Jop.2013.001275  0.305
2014 Lee JH, Cragun D, Thompson Z, Coppola D, Nicosia SV, Akbari M, Zhang S, McLaughlin J, Narod S, Schildkraut J, Sellers TA, Pal T. Association between IHC and MSI testing to identify mismatch repair-deficient patients with ovarian cancer. Genetic Testing and Molecular Biomarkers. 18: 229-35. PMID 24592941 DOI: 10.1089/Gtmb.2013.0393  0.319
2014 Dalia S, Chavez J, Little B, Bello C, Fisher K, Lee JH, Chervenick P, Sokol L, Sotomayor E, Shah B. Serum albumin retains independent prognostic significance in diffuse large B-cell lymphoma in the post-rituximab era. Annals of Hematology. 93: 1305-12. PMID 24590536 DOI: 10.1007/S00277-014-2031-2  0.32
2014 Lee JH, Fulp W, Wells KJ, Meade CD, Calcano E, Roetzheim R. Effect of patient navigation on time to diagnostic resolution among patients with colorectal cancer-related abnormalities. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 29: 144-50. PMID 24113902 DOI: 10.1007/S13187-013-0561-2  0.336
2014 Padron E, Garcia-Manero G, Patnaik MM, Itzykson R, Lasho T, Nazha A, Rampal RK, Sanchez ME, Jabbour E, Al Ali NH, Thompson Z, Lee J, Colla S, Fenaux P, Kantarjian HM, et al. An International Data Set for the Study of Chronic Myelomonocytic Leukemia (CMML) Validates Modern Prognostic Scoring Systems and Demonstrates a Critical Need for Novel Prognostication Strategies Blood. 124: 530-530. DOI: 10.1182/Blood.V124.21.530.530  0.307
2014 Rollison DE, Shain KH, Lee J, Hampras SS, Fisher K, Al Ali NH, Padron E, Lancet JE, Olesnyckyj M, Kenvin L, Knight RD, Dalton W, List AF, Komrokji R. Subsequent Primary Malignancies Among Myelodysplastic Syndrome Patients Treated with or without Lenalidomide Blood. 124: 413-413. DOI: 10.1182/Blood.V124.21.413.413  0.345
2014 Rollison DE, Shain KH, Lee J, Hampras SS, Fulp W, Fisher K, Al Ali NH, Padron E, Lancet J, Xu Q, Knight RD, List AF, Dalton W, Komrokji R. Lenalidomide and Risk of Acute Myeloid Leukemia (AML) Transformation Among Myelodysplastic Syndrome (MDS) Patients Blood. 124: 1912-1912. DOI: 10.1182/Blood.V124.21.1912.1912  0.311
2014 Sehovic I, Block R, Clayman ML, Eggly S, Hayes-Lattin B, Kelvin J, Lee J, Reinecke J, Vadaparampil ST, Quinn GP. Abstract C44: Gender disparities in documentation of fertility risks among adolescents and young adults with cancer Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-C44  0.365
2013 Ferrante JM, Lee JH, McCarthy EP, Fisher KJ, Chen R, Gonzalez EC, Love-Jackson K, Roetzheim RG. Primary care utilization and colorectal cancer incidence and mortality among Medicare beneficiaries: a population-based, case-control study. Annals of Internal Medicine. 159: 437-46. PMID 24081284 DOI: 10.7326/0003-4819-159-7-201310010-00003  0.301
2013 Lee JH, Fulp W, Wells KJ, Meade CD, Calcano E, Roetzheim R. Patient navigation and time to diagnostic resolution: results for a cluster randomized trial evaluating the efficacy of patient navigation among patients with breast cancer screening abnormalities, Tampa, FL. Plos One. 8: e74542. PMID 24066145 DOI: 10.1371/Journal.Pone.0074542  0.329
2013 Fisher KJ, Lee JH, Ferrante JM, McCarthy EP, Gonzalez EC, Chen R, Love-Jackson K, Roetzheim RG. The effects of primary care on breast cancer mortality and incidence among Medicare beneficiaries. Cancer. 119: 2964-72. PMID 23677482 DOI: 10.1002/Cncr.28148  0.329
2013 Anic GM, Sondak VK, Messina JL, Fenske NA, Zager JS, Cherpelis BS, Lee JH, Fulp WJ, Epling-Burnette PK, Park JY, Rollison DE. Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. Cancer Epidemiology. 37: 434-9. PMID 23523330 DOI: 10.1016/J.Canep.2013.02.010  0.328
2013 Soliman H, Rawal B, Fulp J, Lee JH, Lopez A, Bui MM, Khalil F, Antonia S, Yfantis HG, Lee DH, Dorsey TH, Ambs S. Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry. Cancer Immunology, Immunotherapy : Cii. 62: 829-37. PMID 23344392 DOI: 10.1007/S00262-013-1393-Y  0.32
2013 Tanvetyanon T, Lee J, Fulp WJ, Jacobsen PB. Impact of performance evaluation on the quality of care in non-small cell lung cancer. Journal of Clinical Oncology. 31: 6531-6531. DOI: 10.1200/Jco.2013.31.15_Suppl.6531  0.338
2013 Dalia S, Conley AP, Fisher K, Lee J, Wenham RM, Apte S, Gonzalez RJ. Clinicopathologic predictors (CP) of survival in patients with endometrial stromal sarcomas (ESS) treated with multi-modality therapy. Journal of Clinical Oncology. 31: 10556-10556. DOI: 10.1200/Jco.2013.31.15_Suppl.10556  0.331
2013 Dalia S, Chavez JC, Bello CM, Chervenick PA, Little BJ, Al Ali NH, Sokol L, Sotomayor EM, Lee J, Fisher K, Thompson Z, Choi B, Shah BD. A New Prognostic Index In Diffuse Large B-Cell Lymphoma Using Serum Albumin: A Pilot Study Evaluating The Albumin Adjusted-International Prognostic Index (A-IPI) Blood. 122: 4267-4267. DOI: 10.1182/Blood.V122.21.4267.4267  0.316
2012 Gray JE, Siegel E, Lee JH, Fulp WJ, Jacobsen PB. Re-assessment of surgical breast cancer quality indicators by the Florida Initiative for Quality Cancer Care (FIQCC) consortium. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 84. PMID 28146824 DOI: 10.1200/Jco.2012.30.27_Suppl.84  0.316
2012 Laronga C, Siegel E, Lee JH, Fulp WJ, Fletcher M, Jacobsen PB. An overview of breast medical oncology documentation through the Florida Initiative on Quality Cancer Care (FIQCC): The Phase II 2009 results. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 73. PMID 28146814 DOI: 10.1200/Jco.2012.30.27_Suppl.73  0.306
2012 Roetzheim RG, Lee JH, Calcano ER, Meade CD, Fulp WJ, Wells KJ. Diagnostic resolution of cancer screening abnormalities at community health centers. Journal of Health Care For the Poor and Underserved. 23: 1280-93. PMID 24212174 DOI: 10.1353/Hpu.2012.0119  0.343
2012 Wells KJ, Lee JH, Calcano ER, Meade CD, Rivera M, Fulp WJ, Roetzheim RG. A cluster randomized trial evaluating the efficacy of patient navigation in improving quality of diagnostic care for patients with breast or colorectal cancer abnormalities. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1664-72. PMID 23045541 DOI: 10.1158/1055-9965.Epi-12-0448  0.38
2012 Roetzheim RG, Ferrante JM, Lee JH, Chen R, Love-Jackson KM, Gonzalez EC, Fisher KJ, McCarthy EP. Influence of primary care on breast cancer outcomes among Medicare beneficiaries. Annals of Family Medicine. 10: 401-11. PMID 22966103 DOI: 10.1370/Afm.1398  0.343
2012 Eschrich SA, Fulp WJ, Pawitan Y, Foekens JA, Smid M, Martens JW, Echevarria M, Kamath V, Lee JH, Harris EE, Bergh J, Torres-Roca JF. Validation of a radiosensitivity molecular signature in breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5134-43. PMID 22832933 DOI: 10.1158/1078-0432.Ccr-12-0891  0.348
2012 Christie J, Quinn GP, Malo T, Lee JH, Zhao X, McIntyre J, Brzosowicz J, Jacobsen PB, Vadaparampil ST. Cognitive and psychological impact of BRCA genetic counseling in before and after definitive surgery breast cancer patients. Annals of Surgical Oncology. 19: 4003-11. PMID 22766984 DOI: 10.1245/S10434-012-2460-X  0.307
2012 Extermann M, Fulp WJ, Lee J, Kish JA, Sehovic M, Poon D, Gwede C. Quality of life of elderly patients undergoing concomitant chemoradiation therapy for head and neck cancers, including assessment of geriatric parameters. Journal of Clinical Oncology. 30: 6100-6100. DOI: 10.1200/Jco.2012.30.15_Suppl.6100  0.306
2012 Torres-Roca JF, Fulp WJ, Pawitan Y, Foekens J, Smid M, Kamath V, Echevarria M, Lee J, Harris EE, Bergh J, Eschrich S. Abstract 678: Validation of a radiosensitivity molecular signature in breast cancer Cancer Research. 72: 678-678. DOI: 10.1158/1538-7445.Am2012-678  0.348
2012 Tung K, Viscidi RP, Helzlsouer KJ, Lee J, Fulp WJ, Giuliano AR, Platz EA, Rollison DE. Abstract 5490: Prospective study of seroreactivity to JC virus T-Antigen and risk of colorectal cancers and adenomas Cancer Research. 72: 5490-5490. DOI: 10.1158/1538-7445.Am2012-5490  0.319
2012 Siegel EM, Jacobsen PB, Lee J, Fulp WJ, Fletcher M, Shibata D. The Florida Initiative for Quality Cancer Care (FIQCC): Improvements in colorectal cancer surgical pathologic quality indicator compliance over a 3-year interval Journal of the American College of Surgeons. 215. DOI: 10.1016/J.Jamcollsurg.2012.06.271  0.323
2011 Gray JE, Laronga C, Siegel EM, Lee JH, Fulp WJ, Fletcher M, Schreiber F, Brown R, Levine R, Cartwright T, Abesada-Terk G, Kim G, Alemany C, Faig D, Sharp P, et al. Degree of variability in performance on breast cancer quality indicators: findings from the Florida initiative for quality cancer care. Journal of Oncology Practice / American Society of Clinical Oncology. 7: 247-51. PMID 22043190 DOI: 10.1200/Jop.2010.000174  0.325
2011 Ferrante JM, McCarthy EP, Gonzalez EC, Lee JH, Chen R, Love-Jackson K, Roetzheim RG. Primary care utilization and colorectal cancer outcomes among medicare beneficiaries Archives of Internal Medicine. 171: 1747-1757. PMID 22025432 DOI: 10.1001/Archinternmed.2011.470  0.303
2011 Wells KJ, Meade CD, Calcano E, Lee JH, Rivers D, Roetzheim RG. Innovative approaches to reducing cancer health disparities: the Moffitt Cancer Center Patient Navigator Research Program. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 26: 649-57. PMID 21573740 DOI: 10.1007/S13187-011-0238-7  0.329
2011 Luque JS, Tyson DM, Markossian T, Lee JH, Turner R, Proctor S, Menard J, Meade CD. Increasing cervical cancer screening in a Hispanic migrant farmworker community through faith-based clinical outreach. Journal of Lower Genital Tract Disease. 15: 200-4. PMID 21427607 DOI: 10.1097/Lgt.0B013E318206004A  0.301
2011 Vadaparampil ST, Quinn GP, Lee J, Malo T, Zhao X, Miree C, Brzosowicz J. Satisfaction with physician recommendation for and information about genetic counseling among breast cancer patients. Breast Journal. 17: 79-82. PMID 21129092 DOI: 10.1111/J.1524-4741.2010.01027.X  0.319
2011 Jacobsen PB, Shibata D, Siegel EM, Lee JH, Fulp WJ, Alemany C, Abesada-Terk G, Brown R, Cartwright T, Faig D, Kim G, Levine R, Markham MJ, Schreiber F, Sharp P, et al. Evaluating the quality of psychosocial care in outpatient medical oncology settings using performance indicators. Psycho-Oncology. 20: 1221-7. PMID 20878724 DOI: 10.1002/Pon.1849  0.304
2011 Abdulla R, Quinn G, Gwede C, Ealey J, Vadaparampil S, Lee J, Shibata D, Elliott G, Lopez D, Roetzheim R, Meade C. Abstract B91: Strategies toward improving the uptake of colorectal cancer screening among underserved communities: Providers’ perspectives Cancer Epidemiology, Biomarkers & Prevention. 20. DOI: 10.1158/1055-9965.Disp-11-B91  0.318
2011 Roetzheim RG, Ferrante JM, Lee J, Chen R, Love-Jackson KM, Gonzalez EC, McCarthy EP. Abstract B68: The influence of primary care on breast cancer outcomes among Medicare beneficiaries Cancer Epidemiology, Biomarkers & Prevention. 20. DOI: 10.1158/1055-9965.Disp-11-B68  0.36
2011 Wells KJ, Arevalo M, Calcano ER, Lee J, Fulp WJ, Meade CD, Roetzheim RG. Abstract B100: Does patient navigation improve outcomes following a breast or colorectal screening abnormality? Outcomes of the Moffitt Cancer Center Patient Navigation Research Program Cancer Epidemiology, Biomarkers & Prevention. 20. DOI: 10.1158/1055-9965.Disp-11-B100  0.377
2011 Ealey J, Meade CD, Gwede CK, Quinn G, Abdulla R, Vadaparampil S, Lee J, Shibata D, Roetzheim R, Elliott G, Lopez D. Abstract A9: Patients’ perspectives on immunochemical fecal occult blood test (I-FOBT or FIT): Not your father's FOBT Cancer Epidemiology, Biomarkers & Prevention. 20. DOI: 10.1158/1055-9965.Disp-11-A9  0.331
2010 Tanvetyanon T, Corman M, Fulp WJ, Lee J, Jacobsen PB. Quality of care in non-small cell lung cancer (NSCLC): Findings from the Florida Initiative for Quality Cancer Care (FIQCC). Journal of Clinical Oncology. 28: 6018-6018. DOI: 10.1200/Jco.2010.28.15_Suppl.6018  0.314
2009 Siegel E, Shibata D, Malaga M, Fulp W, Lee J, Jacobsen P. Impact of patient age on quality of care in the treatment of colorectal cancer: Results from the Florida Initiative for Quality Cancer Care (FIQCC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6548. PMID 27964064 DOI: 10.1200/Jco.2009.27.15_Suppl.6548  0.325
2009 Shibata D, Siegel E, Malafa M, Lee J, Fulp W, Jacobsen P. Adherence to National Quality Forum (NQF) colorectal cancer indicators among members of the Florida Initiative for Quality Cancer Care (FIQCC) consortium. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6563. PMID 27963801 DOI: 10.1200/Jco.2009.27.15_Suppl.6563  0.335
2009 Jacobsen PB, Shibata D, Siegel EM, Lee JH, Alemany CA, Brown R, Cartwright TH, Levine RM, Smith JC, Abesada-Terk G, Malafa MP. Initial evaluation of quality indicators for psychosocial care of adults with cancer. Cancer Control : Journal of the Moffitt Cancer Center. 16: 328-34. PMID 19910919 DOI: 10.1177/107327480901600407  0.319
2009 Malafa MP, Corman MM, Shibata D, Siegel EM, Lee J, Jacobsen PB. The Florida Initiative for Quality Cancer Care: a regional project to measure and improve cancer care. Cancer Control. 16: 318-327. PMID 19910918 DOI: 10.1177/107327480901600406  0.345
2009 Quinn G, Vadaparampil ST, Jacobsen P, Lee J, Lancaster J, Bepler G, Keefe DL, Albrecht TL. National survey of physicians practice patterns: Fertility preservation and cancer patients Journal of Clinical Oncology. 27. DOI: 10.1200/Jco.2009.27.18_Suppl.Cra9508  0.335
2009 Gray J, Laronga C, Siegel E, Lee J, Fulp W, Jacobson P. Medical Oncology Breast Cancer Quality Indicators: Adherence by the Florida Initiative for Quality Cancer Care (FIQCC) Consortium. Cancer Research. 69: 1078-1078. DOI: 10.1158/0008-5472.Sabcs-09-1078  0.361
2008 Pal T, Coppola D, Nicosia S, Zhang S, Lee J, Wey J, Sutphen R, Schildkraut J, Narod S, Sellers T. Abstract PR-2: Investigation of mismatch repair deficiency in ovarian cancers Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-Pr-2  0.308
2007 Jacobsen PB, Shibata D, Siegel EM, Druta M, Lee JH, Marshburn J, Davenport L, Cruse H, Levine R, Gondi A, Brown R, Malafa M. Measuring quality of care in the treatment of colorectal cancer: the moffitt quality practice initiative. Journal of Oncology Practice / American Society of Clinical Oncology. 3: 60-5. PMID 20859375 DOI: 10.1200/Jop.0722002  0.319
2006 Diaz N, Minton S, Cox C, Bowman T, Gritsko T, Garcia R, Eweis I, Wloch M, Livingston S, Seijo E, Cantor A, Lee JH, Beam CA, Sullivan D, Jove R, et al. Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 20-8. PMID 16397019 DOI: 10.1158/1078-0432.Ccr-04-1749  0.316
2005 Hensing TA, Schell MJ, Lee JH, Socinski MA. Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 47: 253-9. PMID 15639724 DOI: 10.1016/J.Lungcan.2004.07.040  0.3
2005 Lee JIH, Qaqish BF. A latent changepoint model using a generalized estimating equations approach Communications in Statistics - Theory and Methods. 34: 1233-1242. DOI: 10.1081/Sta-200056815  0.511
2004 Lee JH, Qaqish BF. Modified GEE and goodness of the marginal fit (GOMF) test with correlated binary responses for contingency tables Biometrical Journal. 46: 675-686. DOI: 10.1002/Bimj.200410071  0.488
2003 Socinski MA, Neubauer MA, Olivares J, Ketchel S, Tynan M, Moore M, Lee J, Davis K, Schell M, Garfield D. Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer Lung Cancer. 40: 91-97. PMID 12660013 DOI: 10.1016/S0169-5002(02)00527-5  0.312
2002 Socinski MA, Schell MJ, Peterman A, Bakri K, Yates S, Gitten R, Unger P, Lee J, Lee JH, Tynan M, Moore M, Kies MS. Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 1335-43. PMID 11870177 DOI: 10.1200/Jco.20.5.1335  0.301
Show low-probability matches.